SCARA5 and pancreatic neoplasm: In pancreatic cancer, CAF-derived EVs containing elevated levels of miR-331-3p enhance the proliferation migration and invasive potentials of cancer cells by inhibiting scavenger receptor class A member 5 (SCARA5) expression and activation of the focal adhesion kinase (FAK) pathway [271].